- Investing Ideas
- /
- Capital Goods Healthcare Sector
Capital Goods Healthcare Sector
Results
2301
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2301 companies
Allarity Therapeutics
Market Cap: US$14.3m
A clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs.
ALLR
US$0.93
7D
-14.1%
1Y
-94.8%
MEI Pharma
Market Cap: US$14.3m
A clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.
MEIP
US$2.09
7D
-2.8%
1Y
-28.4%
Equillium
Market Cap: US$14.3m
A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.
EQ
US$0.38
7D
-2.5%
1Y
-72.8%
Neurotech International
Market Cap: AU$22.0m
A clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia.
NTI
AU$0.021
7D
-8.7%
1Y
-70.8%
Edesa Biotech
Market Cap: US$14.1m
A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.
EDSA
US$1.99
7D
-0.5%
1Y
-52.1%
Bioxytran
Market Cap: US$14.0m
A clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans.
BIXT
US$0.16
7D
13.2%
1Y
22.3%
Lumos Diagnostics Holdings
Market Cap: AU$21.7m
Develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States and Australia.
LDX
AU$0.027
7D
3.8%
1Y
-25.0%
Cingulate
Market Cap: US$13.8m
A biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
CING
US$4.00
7D
20.1%
1Y
-52.4%
NextCure
Market Cap: US$13.8m
A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
NXTC
US$0.47
7D
-7.9%
1Y
-71.0%
Lifeward
Market Cap: US$13.6m
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
LFWD
US$1.23
7D
3.4%
1Y
-72.7%
Ventripoint Diagnostics
Market Cap: CA$18.8m
A medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide.
VPT
CA$0.12
7D
-4.2%
1Y
-47.7%
BiomX
Market Cap: US$13.5m
A clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases.
PHGE
US$0.50
7D
-5.8%
1Y
-85.7%
Synlogic
Market Cap: US$13.5m
A biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States.
SYBX
US$1.14
7D
0.3%
1Y
-29.0%
PharmaTher Holdings
Market Cap: CA$18.6m
A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.
PHRM
CA$0.20
7D
-2.4%
1Y
0%
BioRestorative Therapies
Market Cap: US$13.4m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.76
7D
13.4%
1Y
37.3%
Vivos Therapeutics
Market Cap: US$13.4m
Operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
VVOS
US$2.29
7D
10.1%
1Y
16.8%
iBio
Market Cap: US$13.4m
A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases.
IBIO
US$0.81
7D
4.6%
1Y
-67.4%
ModivCare
Market Cap: US$13.3m
A technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members in the United States.
MODV
US$0.89
7D
0.5%
1Y
-96.8%
Next Science
Market Cap: AU$20.7m
Engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand.
NXS
AU$0.07
7D
-19.5%
1Y
-72.0%
Rallybio
Market Cap: US$13.3m
A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.
RLYB
US$0.34
7D
3.4%
1Y
-77.1%
Proteome Sciences
Market Cap: UK£9.9m
Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.
PRM
UK£0.033
7D
-16.5%
1Y
-10.9%
Curative Biotechnology
Market Cap: US$13.2m
A development-stage biomedical company, develops, licenses, and commercializes pharmaceutical products and medical devices.
CUBT
US$0.014
7D
-2.2%
1Y
-14.1%
Orgenesis
Market Cap: US$13.1m
A biotech company, focuses on cell and gene therapies worldwide.
ORGS
US$2.00
7D
-0.5%
1Y
-60.0%
Portage Biotech
Market Cap: US$13.1m
A clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products.
PRTG
US$8.03
7D
-0.7%
1Y
56.8%
Biotricity
Market Cap: US$13.1m
A medical technology company, provides biometric data monitoring solutions in the United States.
BTCY
US$0.50
7D
-3.8%
1Y
-56.1%
IN8bio
Market Cap: US$13.1m
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.
INAB
US$0.14
7D
12.7%
1Y
-86.1%
Abpro Holdings
Market Cap: US$13.1m
A biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology.
ABP
US$0.26
7D
0.7%
1Y
-97.7%
CardieX
Market Cap: AU$20.3m
Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.
CDX
AU$0.05
7D
2.0%
1Y
-16.7%
Resonance Health
Market Cap: AU$20.2m
A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in Australia, the Asia Pacific, North America, Europe, the Middle East, and Africa.
RHT
AU$0.044
7D
15.8%
1Y
-29.0%
Meihua International Medical Technologies
Market Cap: US$13.0m
Meihua International Medical Technologies Co., Ltd.
MHUA
US$0.41
7D
10.6%
1Y
-36.1%
BLIS Technologies
Market Cap: NZ$21.7m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.
BLT
NZ$0.017
7D
6.3%
1Y
-5.6%
CEL-SCI
Market Cap: US$12.9m
A clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.
CVM
US$2.50
7D
-44.6%
1Y
-93.4%
Veri Medtech Holdings
Market Cap: US$12.8m
Provides health and wellness services and products through its healthcare technology platform.
VRHI
US$0.64
7D
-10.5%
1Y
105.8%
Conavi Medical
Market Cap: CA$17.7m
Focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures.
CNVI
CA$0.40
7D
-1.3%
1Y
n/a
Unity Biotechnology
Market Cap: US$12.7m
A biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.
UBX
US$0.68
7D
-7.6%
1Y
-56.6%
Neuphoria Therapeutics
Market Cap: US$12.7m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$6.52
7D
17.9%
1Y
n/a